Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Syndecan 1 Antikörper

SDC1 Reaktivität: Human FACS, IHC (p) Wirt: Maus Monoclonal 15-11-14 unconjugated
Produktnummer ABIN487501
  • Target Alle Syndecan 1 (SDC1) Antikörper anzeigen
    Syndecan 1 (SDC1)
    Reaktivität
    • 103
    • 44
    • 42
    • 17
    • 5
    Human
    Wirt
    • 64
    • 43
    • 10
    • 1
    Maus
    Klonalität
    • 65
    • 53
    Monoklonal
    Konjugat
    • 52
    • 12
    • 9
    • 9
    • 8
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Syndecan 1 Antikörper ist unkonjugiert
    Applikation
    • 63
    • 41
    • 40
    • 27
    • 14
    • 13
    • 12
    • 11
    • 10
    • 10
    • 8
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Spezifität
    Recognizes CD138/Syndecan-1.
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human.
    Produktmerkmale
    Synonyms: SYND1, SDC1, SDC
    Aufreinigung
    Protein-A Sepharose Chromatography of hybridoma supernatant.
    Immunogen
    XG1 and U266 myeloma cell lines. Remarks: Hybridoma was established by fusion of mouse myeloma cell Sp2/0 with Balb/cmouse splenocyte.
    Klon
    15-11-14
    Isotyp
    IgG1
    Top Product
    Discover our top product SDC1 Primärantikörper
  • Applikationshinweise
    Flow Cytometry: 10-20 μg/mL (final concentration). Positive Control: KM3, RPMI8226, U226. Immunohistochemistry on Paraffin Sections: 1-5 μg/mL. Heat treatment is necessary for paraffin embedded sections. Microwave oven: 2 times for 10 minutes each in 10 mM citrate buffer ( pH 6.5). Positive Controls: Lung, Adenocarcinoma, Tonsil. Detailed procedure is provided in Protocols.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Protokoll
    Flow cytometric analysis for floating cellsWe usually use Fisher tubes or equivalents as reaction tubes for all step described below. 1) Wash the cells 3 times with washing buffer [PBS containing 2% fetal calf serum (FCS) and0. 1% NaN]. 2) Resuspend the cells with washing buffer (5x10e6 cells/mL). 3) Add 50 µL of the cell suspension into each tube, and centrifuge at 500 x g for 1 minute atroom temperature (20~25°C). Remove supernatant by careful aspiration. 4) Add 20 µL of Clear Back (human Fc receptor blocking reagent) to the cell pellet aftertapping. Mix well and incubate for 5 minutes at room temperature. 5) Add 40 µl of the primary antibody at the concentration of as suggest in theAPPLICATIONS diluted in the washing buffer. Mix well and incubate for 30 minutes at roomtemperature. 6) Add 1 mL of the washing buffer followed by centrifugation at 500 x g for 1 minute at roomtemperature. Remove supernatant by careful aspiration. 7) Add 30 µL of 1: 40 FITC conjugated anti-mouse IgG diluted with the washing buffer. Mixwell and incubate for 15 minutes at room temperature. 8) Add 1 mL of the washing buffer followed by centrifugation at 500 x g for 1 minute at roomtemperature. Remove supernatant by careful aspiration. 9) Resuspend the cells with 500 µL of the washing buffer and analyze by a flow cytometer. Positive controls for Flow cytometry: KM3, RPMI8226, U226Flow cytometric analysis for whole blood cellsWe usually use Falcon tubes or equivalents as reaction tubes for all step described below. 1) Add 20 µL of the anti-Syndecan-1/CD138 monoclonal antibody (50 µg/mL) diluted withwashing buffer [PBS containing 2% fetal calf serum (FCS) and 0. 1% NaN3] into each tube. 2) Add 50 µL of whole blood into each tube. Mix well, and incubate for 30 minutes at roomtemperature (20~25°C). 3) Add 2 mL of the washing buffer followed by centrifugation at 500 x g for 1 minute at roomtemperature. Remove supernatant by careful aspiration. 4) Add 50 µL of secondary antibody 1: 40 FITC conjugated anti-Mouse IgG diluted with thewashing buffer. Mix well and incubate for 15 minutes at room temperature. 5) Lyse with OptiLyse C (for analysis on Beckman Coulter instruments) or OptiLyse B (foranalysis on BD instruments), using the procedure recommended in the respective packageinserts. 6) Resuspend the cells with 500 µL of the washing buffer and analyze by a flow cytometer. Immunohistochemical Staining for Paraffin-Embedded Sections: SAB method1) Deparaffinize the sections with Xylene 3 times for 3-5 minutes each.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    PBS, pH 7.2 containing 50 % Glycerol without preservatives.
    Konservierungsmittel
    Without preservative
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store the antibody (in aliquots) at -20 °C. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.
    Haltbarkeit
    12 months
  • Target
    Syndecan 1 (SDC1)
    Andere Bezeichnung
    CD138 / Syndecan-1 (SDC1 Produkte)
    Synonyme
    CG10497 antikoerper, CT27296 antikoerper, Dmel\\CG10497 antikoerper, Dsyn antikoerper, Syd antikoerper, Syn antikoerper, dSdc antikoerper, l(2)10608 antikoerper, sdc antikoerper, syd antikoerper, syn antikoerper, Syn1 antikoerper, cd138 antikoerper, synd1 antikoerper, xSyn1 antikoerper, syndecan1 antikoerper, Syndecan-1 antikoerper, XSyndecan-1 antikoerper, SDC1 antikoerper, CD138 antikoerper, SDC antikoerper, SYND1 antikoerper, syndecan antikoerper, AA408134 antikoerper, AA409076 antikoerper, Sstn antikoerper, Synd antikoerper, Synd1 antikoerper, syn-1 antikoerper, HSPG antikoerper, SYNDECA antikoerper, Syndecan antikoerper, Syndecan antikoerper, syndecan 1 antikoerper, Sdc antikoerper, sdc1 antikoerper, SDC1 antikoerper, Sdc1 antikoerper
    Hintergrund
    Syndecan-1 (CD138) is a heparan sulfate proteoglycan expressed on the surface of plasma cel1s and some epithelial cells where it mediates cell-cell and cell-extracellular matrix adhesion, and may facilitate the binding of growth factors to their high-affinity receptors as shown for basic fibroblast growth factor (b-FGF). It has been reported that altered expression of syndecan-1 in several tumors such as colorectal cancer, esophageal carcinoma, lung carcinoma, gastric cancer and multiple myeloma, and alteration of syndecan-1 expression in the tumors correlated with patients survival rate, stage, or metastasis.Synonyms: SDC, SDC1, SYND1
    Gen-ID
    6382
    UniProt
    P18827
    Pathways
    Glycosaminoglycan Metabolic Process, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Lipid Metabolism
Sie sind hier:
Kundenservice